Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London · Delayed Price · Currency is GBP · Price in USD 589.27
+3.68 (0.63%)
At close: Aug 27, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 44.48 billion as of August 29, 2025. Its market cap has decreased by -54.37% in one year.
Market Cap
44.48B
Enterprise Value
33.51B
Revenue
10.37B
Ranking
n/a
PE Ratio
13.67
Stock Price
589.27
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 44.48B, an increase of 46,180.97%. That is a compound annual growth rate of 20.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 44.48B | -27.33% |
| Dec 31, 2024 | 61.22B | -16.52% |
| Dec 29, 2023 | 73.33B | 14.66% |
| Dec 30, 2022 | 63.95B | 31.15% |
| Dec 31, 2021 | 48.76B | 30.57% |
| Dec 31, 2020 | 37.35B | 20.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.16B |
| GSK plc | 58.90B |
| Haleon | 32.25B |
| Smith & Nephew | 12.04B |
| ConvaTec Group | 4.77B |
| Hikma Pharmaceuticals | 4.08B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.88B |